Location: Leipzig - Sachsen
News from To strengthen its cutting-edge research, Leipzig University submitted three draft proposals yesterday (Wednesday, 31 May 2023) in the Clusters of Excellence funding line in the second competition phase of the Excellence Strategy of the German federal and state governments. The research projects described in the draft proposals come from innovative collaborations in the fields of medicine, environmental sciences, life sciences, social sciences and natural sciences.
Cis-tetrahydrocannabinoids can now be produced synthetically, enabling pharmaceutical applications A group of researchers at Leipzig University has developed a new method for synthesising cis-tetrahydrocannabinol (THC) - a natural substance found in the cannabis plant that produces the characteristic psychoactive effect and has many potential applications, including in the pharmaceutical industry.
22 April is Earth Day, an annual event to show support for the environment. Two junior professors have been appointed to strengthen Leipzig University's commitment to climate research: Junior Professors Marlene Kretschmer and Sebastian Sippel's research includes climate extremes and attribution, which is the process of linking extreme events to human-induced climate change.
The human body contains more than 30 trillion cells. Until recently, the sheer number of cells in the organism meant that approaches to understanding human diseases and developmental processes based on the analysis of single cells were a futuristic vision.
The number of people with dementia is increasing. Therefore, early detection and diagnosis of the age-related disease are becoming increasingly important. Researchers at the Institute of Social Medicine, Occupational Medicine and Public Health (ISAP) at the University of Leipzig have conducted a representative survey to investigate the attitudes of people aged 60 and over toward early diagnosis of dementia: they analyzed data from two telephone surveys and compared the results.
More than half of people with chronic hepatitis B have a form of the disease in which the immune system almost never achieves sustained control, despite many years of treatment. According to current knowledge, those affected therefore require lifelong drug therapy.